The Pet Industry Federation (PIF) has launched a sector-wide member consultation to gather industry views on the potential future regulation of flea treatment products.
The move follows a Call for Evidence initiated by the Veterinary Medicines Directorate (VMD) to examine the environmental impact of certain parasiticide products containing fipronil and imidacloprid. The VMD has suggested that changing the licensed status of such products, allowing them only to be sold by vets or Suitably Qualified Persons (SQPs) rather than high street retailers, could alleviate the issue.
PIF believes it is important that the practical realities faced by pet businesses and the wider impact on pet owners and animal welfare, are fully understood before any decisions are taken. Potential changes could affect a range of businesses across the sector, including pet retailers, groomers and boarding establishments through reduced sales, inconvenience for owners and knock-on effects for businesses dealing with untreated pets.
PIF chief executive Nigel Baker said: “This is an important issue with implications for businesses, pet owners and animal welfare. It is essential that policymakers hear from those working directly with pets and pet owners every day. We want to understand members’ views, concerns and practical experiences so that we can represent the sector in a balanced and constructive way.”
PIF has launched separate surveys for its members including pet retailers, groomers and boarding establishments, with findings helping to shape its response and wider discussions with industry stakeholders. As well as gathering member evidence, PIF is also engaging with National Office of Animal Health (NOAH) as part of wider industry dialogue on the issue.
PIF members are encouraged to complete the survey by Tuesday May 5. The VMD Call for Evidence closes on June 11.
